CAS 135529-19-0
:N-[4-[[[4-[[(5-Méthyl-3-isoxazolyl)amino]sulfonyl]phényl]amino]sulfonyl]phényl]acétamide
- N-[4-[[[4-[[(5-Methyl-3-isoxazolyl)amino]sulfonyl]phenyl]amino]sulfonyl]phenyl]acetamide
- Acetamide, N-[4-[[[4-[[(5-methyl-3-isoxazolyl)amino]sulfonyl]phenyl]amino]sulfonyl]phenyl]-
- Lincomycin Impurity 5 Monomer(Lincomycin EP Impurity E Monomer)
- N-(4-Aminobenzenesulfonyl) Sulfamethoxazole N-Acetate
N-(4-{[(4-{[(5-methyl-3-isoxazolyl)amino]sulfonyl}phenyl)amino]sulfonyl}phenyl)acetamide
CAS :Formule :C18H18N4O6S2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :450.4887N-(4-(N-(4-(N-(5-methylisoxazol-3-yl)sulfamoyl)phenyl)sulfamoyl)phenyl)acetamide
CAS :Degré de pureté :95%Masse moléculaire :450.4800109863281N-(4-Aminobenzenesulfonyl) Sulfamethoxazole N-Acetate
CAS :Produit contrôléFormule :C18H18N4O6S2Couleur et forme :NeatMasse moléculaire :450.489N-(4-Aminobenzenesulfonyl) sulfamethoxazole N-acetate
CAS :4-aminobenzenesulfonyl sulfamethoxazole N-acetate is a drug product that has been approved for use in humans. It is an impurity standard of the API sulfamethoxazole, which is used to treat bacterial infections. 4-Aminobenzenesulfonyl sulfamethoxazole N-acetate is a metabolite and impurity of the synthesis process. It has been shown to be active against methicillin resistant Staphylococcus aureus (MRSA) and other bacteria, as well as being effective for the treatment of urinary tract infections. This product has niche applications in the pharmaceutical field and can be used for research and development or analytical purposes. 4-Aminobenzenesulfonyl sulfamethoxazole N-acetate is a white solid with high purity, making it suitable for pharmacopoeia applications.
Formule :C18H18N4O6S2Degré de pureté :Min. 95%Masse moléculaire :450.5 g/mol



